Neonatal hypoglycaemia--a critical reappraisal.
D002395:Catecholamines / Q000627:therapeutic use; D004899:Erythroblastosis, Fetal / Q000150:complications; D005260:Female; D005934:Glucagon / Q000627:therapeutic use; D005938:Glucocorticoids / Q000627:therapeutic use; D005943:Gluconeogenesis; D005947:Glucose / Q000008:administration & dosage; D006801:Humans; D006946:Hyperinsulinism / Q000150:complications; D006982:Hypertonic Solutions; D007003:Hypoglycemia / Q000150:complications / Q000175:diagnosis / Q000188:drug therapy / Q000209:etiology*; D000860:Hypoxia / Q000150:complications; D007231:Infant, Newborn; D007232:Infant, Newborn, Diseases / Q000209:etiology*; D007234:Infant, Premature; D007275:Injections, Intravenous; D007328:Insulin / Q000627:therapeutic use; D008112:Liver Glycogen / Q000378:metabolism; D009461:Neurologic Manifestations; D011247:Pregnancy; D011254:Pregnancy in Diabetics / Q000188:drug therapy; D013453:Sulfonylurea Compounds / Q000627:therapeutic use
D002395:Catecholamines; D005938:Glucocorticoids; D006982:Hypertonic Solutions; D007328:Insulin; D008112:Liver Glycogen; D013453:Sulfonylurea Compounds; D005934:Glucagon; D005947:Glucose